Now Accepting Applications: Research Grants on DCD Organ Preservation and EVLP
ISHLT is accepting applications for two Research Grants covering topics related to the use of hypothermic preservation of organs for donation after circulatory death (DCD) heart transplantation and the development of acellular Ex Vivo Lung Perfusion (EVLP) technologies.
Applications will be accepted until 30 September, 2024 at 11:59 p.m. ET / 1 October, 2024 at 3:59 UTC. Grant recipients will be announced in January 2025 and honored in person at the ISHLT2025 meeting in Boston.
Novel Approaches for FDA Cleared Preservation Systems in Donation After Circulatory Death (DCD) Heart Transplantation Research Grant
Grant Amount: Up to $75,000 USD
Supported by Paragonix Technologies
This grant aims to fund clinical research into novel techniques to expand the donor pool by making the recovery and transportation of DCD organs more cost-effective (reducing costs and/or improving outcomes) through the use of FDA cleared hypothermic (4-80 C.) preservation systems.
The two-year grant will fund studies that utilize novel techniques or approaches at the donor OR recipient site, to enable access and evaluation of DCD hearts transported by hypothermic preservation. Research should be clinical or translational in nature. Consideration will be given to proposals with direct applicability to clinical practice.
Acellular Ex Vivo Lung Perfusion (EVLP) Research Grant
Grant Amount: Up to $37,500 USD
Supported by Lung Bioengineering
The purpose of this grant is to fund research that aims to develop further advancements in acellular Ex Vivo Lung Perfusion (EVLP) technology.
Research topics for this one-year grant could include any of a broad and diverse area of topics, including optimization of perfusion techniques, intervention and repair strategies, immunomodulation and reconditioning, and clinical outcomes research.